UT, ORNL see future of eye disease diagnosis
UTHSC
UTHSC’s Dr. Guy Reed Wins 2016 Innovation Award from Inside Memphis Business Magazine
Guy Reed, MD, began more than a decade ago to research a safer, more effective therapy for dissolving blood clots, which are the cause of most strokes. The outcome of that research is a novel thrombus (blood clot) dissolving agent, TS23, which is currently undergoing clinical trials.
UTRF Health Science Center Office Seeking Commercialization Analyst Intern
Click to apply for UTRF internship.